Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31415 | 123 | 24.5 | 36% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3257 | 1448 | CELL MED//CELL POLYPLOIDY//GRAFT HYBRIDIZATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROBIMANE | Author keyword | 5 | 63% | 4% | 5 |
2 | BIMOLANE | Author keyword | 2 | 44% | 3% | 4 |
3 | BISDIOXOPIPERAZINE COMPOUNDS | Author keyword | 2 | 67% | 2% | 2 |
4 | ANTI METASTATIC DRUGS | Author keyword | 1 | 50% | 1% | 1 |
5 | ANTICANCER PHARMACOLOGY | Author keyword | 1 | 50% | 1% | 1 |
6 | BROAD SPECTRUM ANTICANCER ACTIVITY | Author keyword | 1 | 50% | 1% | 1 |
7 | CONVOLVULUS GALATICUS | Author keyword | 1 | 50% | 1% | 1 |
8 | CROCUS ANTALYENSIS | Author keyword | 1 | 50% | 1% | 1 |
9 | MST 16 | Author keyword | 1 | 22% | 2% | 2 |
10 | PIPERAZINE 2 6 DIONE | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROBIMANE | 5 | 63% | 4% | 5 | Search PROBIMANE | Search PROBIMANE |
2 | BIMOLANE | 2 | 44% | 3% | 4 | Search BIMOLANE | Search BIMOLANE |
3 | BISDIOXOPIPERAZINE COMPOUNDS | 2 | 67% | 2% | 2 | Search BISDIOXOPIPERAZINE+COMPOUNDS | Search BISDIOXOPIPERAZINE+COMPOUNDS |
4 | ANTI METASTATIC DRUGS | 1 | 50% | 1% | 1 | Search ANTI+METASTATIC+DRUGS | Search ANTI+METASTATIC+DRUGS |
5 | ANTICANCER PHARMACOLOGY | 1 | 50% | 1% | 1 | Search ANTICANCER+PHARMACOLOGY | Search ANTICANCER+PHARMACOLOGY |
6 | BROAD SPECTRUM ANTICANCER ACTIVITY | 1 | 50% | 1% | 1 | Search BROAD+SPECTRUM+ANTICANCER+ACTIVITY | Search BROAD+SPECTRUM+ANTICANCER+ACTIVITY |
7 | CONVOLVULUS GALATICUS | 1 | 50% | 1% | 1 | Search CONVOLVULUS+GALATICUS | Search CONVOLVULUS+GALATICUS |
8 | CROCUS ANTALYENSIS | 1 | 50% | 1% | 1 | Search CROCUS+ANTALYENSIS | Search CROCUS+ANTALYENSIS |
9 | MST 16 | 1 | 22% | 2% | 2 | Search MST+16 | Search MST+16 |
10 | PIPERAZINE 2 6 DIONE | 0 | 33% | 1% | 1 | Search PIPERAZINE+2+6+DIONE | Search PIPERAZINE+2+6+DIONE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 1 2 BIS3 5 DIOXOPIPERAZIN 1 YLPROPANE | 1 | 100% | 2% | 2 |
2 | BASIC ELECTRICAL RHYTHM | 1 | 50% | 1% | 1 |
3 | CHEMOPREVENTIVE SELENIUM COMPOUNDS | 1 | 50% | 1% | 1 |
4 | DIOXOPIPERAZINE | 1 | 50% | 1% | 1 |
5 | EXPERIMENTAL UNIT | 1 | 50% | 1% | 1 |
6 | JUN NH2 TERMINAL KINASES | 0 | 14% | 1% | 1 |
7 | DIFFERENT DOSE SCHEDULES | 0 | 11% | 1% | 1 |
8 | VIRUS EXPRESSION VECTORS | 0 | 11% | 1% | 1 |
9 | COMBINED ROTAVIRUS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Standards for veterinary clinical trials | 1995 | 1 | 13 | 69% |
HOMEOPATHY AND ISOPATHY, SCIENCE OR FAITH | 1986 | 1 | 2 | 50% |
Bridging basic science and clinical medicine - Overview | 1995 | 0 | 50 | 16% |
CONTENT OF REPORTS ON CLINICAL-TRIALS - A CRITICAL-REVIEW | 1984 | 54 | 138 | 9% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ELANCO ANIM SCI | 0 | 17% | 0.8% | 1 |
2 | GWATHMEY ADAMS VIS SCI | 0 | 13% | 0.8% | 1 |
3 | HLTH RISK ASSESSMENT | 0 | 13% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000105519 | AMINE ACCUMULATION//CATIONIZED POLYACRYLAMIDE//LONG TERM DEFICITS |
2 | 0.0000091555 | CELL MED//H 1 CELLS//H1 CELLS |
3 | 0.0000054139 | COMPLAINTS PROCEDURE//SERVICE KNOWLEDGE//BEHAVIOR SCALES |
4 | 0.0000053051 | CARDIOTOXICITY//DEXRAZOXANE//DOXORUBICIN |
5 | 0.0000048818 | PHYTOTHER EUT METAB ENDOCRINOL//SIDA RHOMBOIDEA ROXB//HERBAL DRUG TECHNOL |
6 | 0.0000041703 | TGN1412//SAFETY PHARMACOLOGY//REPEAT DOSE TOXICITY STUDIES |
7 | 0.0000041501 | GAMMA GLUTAMYLTAURINE//HUMAN HEPATOCELLULAR CARCINOMA HEPG2 CELLS//CHIRAL COLUMN CHROMATOGRAPHY |
8 | 0.0000041139 | TOPOISOMERASE II//ICRF 193//DNA TOPOISOMERASE II |
9 | 0.0000041115 | ACEMETACIN//ACEMETACINE//CYCLOOXYGENASE 2 SELECTIVE |
10 | 0.0000040594 | TCD50//REPOPULATION//R1H RHABDOMYOSARCOMA |